Delivery Order SPE2DR25D1053-SPE2DR26FT943
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,656.81 by the Defense Logistics Agency (DLA) on November 4, 2025. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of November 4, 2025, and represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,151.06 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on November 17, 2025, under a firm fixed-price contract. This non-set-aside delivery order is expected to be completed by November 18, 2025, and represents a child contract under the company's larger pharmaceutical supply agreement with the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $167,579.24 by the Defense Logistics Agency's Medical Supply Chain on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award demonstrating the vendor's capability to meet federal procurement requirements. The delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $49,771.62 by the Defense Logistics Agency Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitive award utilizes firm fixed price pricing and is not set aside for any specific business category. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,029.60 by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,158.40 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,938.40 by the Defense Logistics Agency's Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,066.68 by the Defense Logistics Agency's Medical Supply Chain on October 14, 2025, with an ultimate completion date of October 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,039,131.66 on November 13, 2025, with a completion date of November 14, 2025. This Firm Fixed Price delivery order, issued without set-aside designation, falls under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT943Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $117,041.96 by the Defense Logistics Agency (DLA) on November 17, 2025, with an ultimate completion date of December 9, 2025. The contract, which is not set-aside and was competitively awarded, involves the supply of BRUKINSA 160 mg tablets (60-count), a specialized pharmaceutical product supporting federal medical procurement needs. This delivery order operates under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive capability in delivering a broad spectrum of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award employs firm fixed pricing and reflects the contractor's established competitiveness in open federal procurement processes. As DLA Troop Support moves forward with establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with potential multiple awards across separate regions, AmerisourceBergen Drug Corp continues to serve as a critical vendor in the federal medical supply chain, supporting military readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $117.0k | 11/17/25 |